FR2834464A1 - Compositions for cleaning rhinopharyngeal mucosa prior to treatment with therapeutic agents comprises surfactant cleansing agents - Google Patents

Compositions for cleaning rhinopharyngeal mucosa prior to treatment with therapeutic agents comprises surfactant cleansing agents Download PDF

Info

Publication number
FR2834464A1
FR2834464A1 FR0200568A FR0200568A FR2834464A1 FR 2834464 A1 FR2834464 A1 FR 2834464A1 FR 0200568 A FR0200568 A FR 0200568A FR 0200568 A FR0200568 A FR 0200568A FR 2834464 A1 FR2834464 A1 FR 2834464A1
Authority
FR
France
Prior art keywords
cleaning
pharmaceutical composition
mucosa
therapeutic
rhynopharyngeal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0200568A
Other languages
French (fr)
Other versions
FR2834464B1 (en
Inventor
Serge Grimberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0200568A priority Critical patent/FR2834464B1/en
Publication of FR2834464A1 publication Critical patent/FR2834464A1/en
Application granted granted Critical
Publication of FR2834464B1 publication Critical patent/FR2834464B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition for rhinopharyngeal use comprises surfactant cleansing agents that may be anionic, cationic, amphoteric or nonionic.

Description

<Desc/Clms Page number 1> <Desc / Clms Page number 1>

Dans le cadre d'un traitement cutané et percutané, un médicament qui ne reste pas en place a une très faible activité. Pour le maintenir en place, différents procédés sont utilisés, par exemple la pommade, mais lorsque la muqueuse provoque une évacuation par du mucus, le produit est rapidement éliminé. As part of skin and percutaneous treatment, a drug that does not stay in place has very low activity. To keep it in place, different methods are used, for example ointment, but when the mucosa causes evacuation by mucus, the product is quickly eliminated.

Dans le cadre présent, la composition pharmaceutique doit contenir des produits que l'on peut qualifier de"nettoyants"comme les tensio-actifs, qu'ils soient anioniques, cationiques, amphotères ou non ioniques, par exemple du polysorbate et de l'essence de Néroli. A ces deux produits chimiques ou à d'autres produits "nettoyants"sont associés deux principes actifs tels que sulfures, antiseptiques, antibiotiques, anti-inflammatoires. In the present context, the pharmaceutical composition must contain products which can be described as "cleaners" such as surfactants, whether anionic, cationic, amphoteric or nonionic, for example polysorbate and gasoline of Neroli. With these two chemicals or with other "cleaning" products are associated two active ingredients such as sulfides, antiseptics, antibiotics, anti-inflammatories.

Le polysorbate et l'essence de Néroli ainsi que les autres produits"nettoyants" permettent un nettoyage de la muqueuse nasale. Donc cette composition pharmaceutique va nettoyer avant de traiter. Pour cela, il est recommandé de bien préciser que le malade doit mettre en place le"médicament"et se moucher copieusement pour nettoyer la muqueuse, puis remettre du"médicament"qui cette fois restera en place et traitera la muqueuse. The polysorbate and the essence of Neroli as well as the other "cleansing" products allow a cleaning of the nasal mucosa. So this pharmaceutical composition will cleanse before treating. For this, it is recommended to make it clear that the patient must put the "medicine" in place and blow his nose thoroughly to clean the mucosa, then add the "medicine" which this time will remain in place and treat the mucosa.

Dans le cadre du nettoyage avec le médicament, le mouchage peut être remplacé par un reniflage et une déglutition. As part of cleaning with the drug, blowing can be replaced by sniffing and swallowing.

Cette composition pharmaceutique est très importante pour amener une véritable activité. Le mouchage ou le reniflage permet d'éliminer tous les germes contenus dans le mucus et libère la muqueuse, cela permet de remettre en place les principes actifs qui soignent la muqueuse.This pharmaceutical composition is very important for bringing about real activity. The blowing or sniffing eliminates all the germs contained in the mucus and frees the mucosa, this allows to replace the active ingredients that treat the mucosa.

Claims (1)

REVENDICATIONS Revendication nO 1 : Composition pharmaceutique pour utilisation rhynopharyngée contenant desCLAIMS Claim 1: Pharmaceutical composition for rhynopharyngeal use containing 1 produits que l'on peut qualifier de"nettoyants"comme les tensio-actifs, qu'ils soient anioniques, cationiques, amphotères ou non ioniques Revendication n 2 : La composition pharmaceutique selon la revendication nO 1 contenant du polysorbate et de l'essence de Néroli.  1 products which can be described as "cleaners" such as surfactants, whether anionic, cationic, amphoteric or non-ionic Claim 2: The pharmaceutical composition according to claim No 1 containing polysorbate and gasoline of Neroli. Revendication n 3 : La composition pharmaceutique, selon les revendications nO 1 et n 2 contenant des principes actifs thérapeutiques tels que sulfures, antiseptiques, antibiotiques, anti-inflammatoires. Claim 3: The pharmaceutical composition according to claims 1 and 2 containing therapeutic active ingredients such as sulphides, antiseptics, antibiotics, anti-inflammatories. présente un effet nettoyant par mouchage et reniflage, la deuxième étape permettant l'activité thérapeutique directe sur la muqueuse nettoyée.  has a cleaning effect by blowing and sniffing, the second step allowing direct therapeutic activity on the cleaned mucosa.
Figure img00020002
Figure img00020002
 Revendication n 4 : Utilisation de la composition pharmaceutique selon l'une des revendications n 1, 2,3 pour la préparation d'un médicament destiné au traitement en 2 étapes de la muqueuse rhinopharyngée Revendication n 5 : Utilisation selon la revendication n 4, caractérisée en ce que la première étape Claim 4: Use of the pharmaceutical composition according to one of Claims 1, 2, 3 for the preparation of a medicament intended for the 2-step treatment of the nasopharyngeal mucosa Claim No 5: Use according to Claim 4, characterized in that the first step /1 / 1 <Desc/Clms Page number 3> <Desc / Clms Page number 3> Composition pharmaceutique à utilisation thérapeutique rhynopharyngée. Pharmaceutical composition for rhynopharyngeal therapeutic use. ABREGE DESCRIPTIF ABSTRACT DESCRIPTION Monsieur Georges Serge GRIMBERG Solution ou suspension rhinopharyngée contenant 2 parties : une partie"nettoyante"et une partie"thérapeutique". La mise en place sur la muqueuse rhynopharyngée deux fois de suite permet le"nettoyage"puis"l'activité thérapeutique". Monsieur Georges Serge GRIMBERG Nasopharyngeal solution or suspension containing 2 parts: a "cleaning" part and a "therapeutic" part. The placement on the rhynopharyngeal mucosa twice in succession allows "cleaning" then "therapeutic activity".
FR0200568A 2002-01-09 2002-01-09 PHARMACEUTICAL COMPOSITIONS FOR RHYNOPHARYNGEAL USE PROVIDING RHYNOPHARYNGE "CLEANING" AND RHYNOPHARYNGEE "THERAPEUTIC" Expired - Fee Related FR2834464B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0200568A FR2834464B1 (en) 2002-01-09 2002-01-09 PHARMACEUTICAL COMPOSITIONS FOR RHYNOPHARYNGEAL USE PROVIDING RHYNOPHARYNGE "CLEANING" AND RHYNOPHARYNGEE "THERAPEUTIC"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200568A FR2834464B1 (en) 2002-01-09 2002-01-09 PHARMACEUTICAL COMPOSITIONS FOR RHYNOPHARYNGEAL USE PROVIDING RHYNOPHARYNGE "CLEANING" AND RHYNOPHARYNGEE "THERAPEUTIC"

Publications (2)

Publication Number Publication Date
FR2834464A1 true FR2834464A1 (en) 2003-07-11
FR2834464B1 FR2834464B1 (en) 2006-01-20

Family

ID=27619520

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200568A Expired - Fee Related FR2834464B1 (en) 2002-01-09 2002-01-09 PHARMACEUTICAL COMPOSITIONS FOR RHYNOPHARYNGEAL USE PROVIDING RHYNOPHARYNGE "CLEANING" AND RHYNOPHARYNGEE "THERAPEUTIC"

Country Status (1)

Country Link
FR (1) FR2834464B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571257A1 (en) * 1984-08-06 1986-04-11 Gros Pierre Composition for humidifying the rhinopharyngeal mucosa
US4966754A (en) * 1988-08-08 1990-10-30 Aveda Corporation Preservation of cosmetic compositions
FR2679775A1 (en) * 1991-08-01 1993-02-05 Grimbert Georges Medicament based on neutralised sulphur-containing derivatives
DE4226217A1 (en) * 1992-08-07 1994-02-10 Reichert Dieter Treatment of "dry nose" using a surfactant - opt. combined with preservatives and/or bactericides and fungicides in physiological saline, to regulate the moisture content of nose and throat
FR2723695A1 (en) * 1994-08-17 1996-02-23 Nathon Roger Nasal soln. contg. mineral water

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571257A1 (en) * 1984-08-06 1986-04-11 Gros Pierre Composition for humidifying the rhinopharyngeal mucosa
US4966754A (en) * 1988-08-08 1990-10-30 Aveda Corporation Preservation of cosmetic compositions
FR2679775A1 (en) * 1991-08-01 1993-02-05 Grimbert Georges Medicament based on neutralised sulphur-containing derivatives
DE4226217A1 (en) * 1992-08-07 1994-02-10 Reichert Dieter Treatment of "dry nose" using a surfactant - opt. combined with preservatives and/or bactericides and fungicides in physiological saline, to regulate the moisture content of nose and throat
FR2723695A1 (en) * 1994-08-17 1996-02-23 Nathon Roger Nasal soln. contg. mineral water

Also Published As

Publication number Publication date
FR2834464B1 (en) 2006-01-20

Similar Documents

Publication Publication Date Title
KR100347651B1 (en) Antimicrobial treatment for herpes simplex virus and other infectious diseases
Anglen Wound irrigation in musculoskeletal injury
Kuckelkorn et al. Emergency treatment of chemical and thermal eye burns
JP5201795B2 (en) Pruritus inhibitor
JPS5870208A (en) Cleaner for contact lens
JP2007513959A (en) Antiviral pharmaceutical composition
WO1997039769A1 (en) Drug composition comprising albumin as active ingredient
ATE211927T1 (en) METHOD FOR VIRUS INACTIVATION IN THE PRESENCE OF A POLYETHER AND AN AGENT
WO2011085155A2 (en) Formulations and methods for dissolving cerumen
WO2000016771A1 (en) Liquid preparations for external use containing sodium cromoglicate and method for treating or preventing eye allergic symptoms
JP4355574B2 (en) Eye drops
JP4737911B2 (en) Eye drops
FR2834464A1 (en) Compositions for cleaning rhinopharyngeal mucosa prior to treatment with therapeutic agents comprises surfactant cleansing agents
Cochran et al. Protothecal olecranon bursitis: treatment with intrabursal amphotericin B
JP5041761B2 (en) Ocular mucosa application
JP2003073303A (en) Method for maintaining refreshing activity of eye drops
Hatai et al. Hydrofluoric acid burns of the eye: report of possible delayed toxicity
FR2827769A1 (en) Compositions useful for cleaning the rhynopharyngeal passages prior to e.g. the administration of active agents via the nasal passages, comprise a polysorbate and Neroli essence
ES2707386T3 (en) Composition for the treatment of HIV or AIDS
JP2023547574A (en) cleaning composition
JP6313598B2 (en) Ophthalmic aqueous composition
JPS6352117A (en) Contact lens processing agent
US20210308436A1 (en) Complete upper respiratory tract cleansing system and its use
JP2006000170A (en) Contact lens composition
JP2002241278A (en) Eyewash and nasal drop containing sodium cromoglycate

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130930